Imaging-based prostate cancer screening among BRCA mutation carriers—results from the first round of screening-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imaging-based prostate cancer screening among BRCA mutation carriers—results from the first round of screening

Published:2020-11 Issue:11 Volume:31 Page:1545-1552
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Segal N.,Ber Y.,Benjaminov O.,Tamir S.,Yakimov M.,Kedar I.,Rosenbaum E.,Sela S.,Ozalvo R.,Shavit-Grievink L.,Keder D.,Baniel J.,Margel D.^ORCID

Funder

ASCO CDA

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference28 articles.

1. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature;Liede;J Clin Oncol,2004

2. Effect of BRCA mutations on metastatic relapse and cause-specific survival after radical treatment for localised prostate cancer;Castro;Eur Urol,2015

3. Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study;Nyberg;Eur Urol,2020

4. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer;Gallagher;Clin Cancer Res,2010

5. Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death;Na;Eur Urol,2017

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening;Urologic Oncology: Seminars and Original Investigations;2024-07

2. Magnetic Resonance Imaging in Prostate Cancer Screening;JAMA Oncology;2024-06-01

3. Magnetic Resonance Imaging–based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study;European Urology Oncology;2024-03

4. Key learning on the promise and limitations of MRI in prostate cancer screening;European Radiology;2024-02-05

5. Incorporating Genetic Risk Into Prostate Cancer Care: Implications for Early Detection and Precision Oncology;JCO Precision Oncology;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3